Clinical challenges: Myeloma and concomitant Type 2 Diabetes
Multiple myeloma is a malignant plasma cell disorder that accounts for approximately 10% of all hematologic cancers. It is characterized by accumulation of clonal plasma cells, predominantly in the bone marrow. The prevalence of type 2 diabetes is increasing; therefore, it is expected that there wi...
Main Authors: | Yasar Albushra Abdul Rahiem Ahmed, Awad Eltayeb |
---|---|
Format: | Article |
Language: | English |
Published: |
Tehran University of Medical Sciences
2013-03-01
|
Series: | International Journal of Hematology-Oncology and Stem Cell Research |
Subjects: | |
Online Access: | https://ijhoscr.tums.ac.ir/index.php/ijhoscr/article/view/463 |
Similar Items
-
Clinical Challenges: Myeloma and Concomitant type 2 Diabetes
by: Yasar Albushra Abdul Rahiem Ahmed, et al.
Published: (2013-01-01) -
Clinical challenges: Myeloma and concomitant type 2 diabetes
by: Mohamed Ahmed Ali, et al.
Published: (2013-01-01) -
A novel combination of bortezomib, lenalidomide, and clarithromycin produced stringent complete response in refractory multiple myeloma complicated with diabetes mellitus – clinical significance and possible mechanisms: a case report
by: Nobuo Takemori, et al.
Published: (2018-02-01) -
Multiple Cranial Nerve Palsy Concomitant with Leptomeningeal Involvement in Multiple Myeloma: A Case Report and Review of Literature
by: Neda Pak, et al.
Published: (2018-01-01) -
Chromosomal aberrations in multiple myeloma: A study on Indian population
by: Angel Beula P. Royal, et al.
Published: (2018-01-01)